Literature DB >> 17396140

Utility of ALK-1 protein expression and ALK rearrangements in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell lesions of the urinary bladder.

William R Sukov1, John C Cheville, Austin W Carlson, Brandon M Shearer, Eli J Piatigorsky, Karen L Grogg, Thomas J Sebo, Jason P Sinnwell, Rhett P Ketterling.   

Abstract

Inflammatory myofibroblastic tumor of the urinary bladder is an unusual spindle cell neoplasm that displays cytologic atypia, infiltrative growth and mitotic activity mimicking malignant tumors, such as leiomyosarcoma, rhabdomyosarcoma and sarcomatoid carcinoma. The objective of this study was to determine if anaplastic lymphoma kinase (ALK-1) protein expression detected by immunohistochemistry and ALK rearrangements detected by fluorescence in situ hybridization (FISH) were useful in distinguishing inflammatory myofibroblastic tumor from malignant spindle cell tumors of the urinary bladder. In inflammatory myofibroblastic tumor, ALK-1 expression was identified in 13 of 21 cases (62%) and ALK rearrangements in 14 of 21 cases (67%). All cases of inflammatory myofibroblastic tumor demonstrating ALK-1 expression, carried ALK rearrangements. One case negative for ALK-1 expression exhibited ALK rearrangement. ALK rearrangements were more common in women (P=0.0032). Leiomyosarcoma, sarcomatoid carcinoma, embryonal rhabdomyosarcoma and reactive myofibroblastic proliferations were negative for ALK-1 protein and ALK rearrangements. Immunohistochemistry using markers of muscle, epithelial, neural, and follicular dendritic cell differentiation showed overlap between inflammatory myofibroblastic tumor with and without ALK gene rearrangements, and between inflammatory myofibroblastic tumor and spindle cell malignancies. However, coexpression of cytokeratin and muscle-specific antigens was unique to inflammatory myofibroblastic tumor, observed in approximately half the tumors. This study indicates that detection of ALK protein and ALK gene rearrangements are useful in distinguishing inflammatory myofibroblastic tumor from spindle cell malignancies in the urinary bladder. Additionally, our findings suggest that ALK rearrangement is the primary mechanism for ALK activation and that inflammatory myofibroblastic tumor likely represents a heterogeneous group of spindle cell proliferations with the majority associated with ALK translocations, and the remaining associated with other etiologies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17396140     DOI: 10.1038/modpathol.3800776

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  24 in total

1.  Pediatric Endobronchial Inflammatory Myofibroblastic Tumor: A Case Report and Review of the Literature.

Authors:  Leilei Liu; Xianglei Kong; Xiaoqian Lu; Dianbo Cao
Journal:  Clin Pract       Date:  2016-12-07

2.  Tumeur myofibroblastique inflammatoire de la vessie.

Authors:  Wafa Jomaa; Sonia Ziadi; Mounir Trimeche; Faten Hammedi; Nabil Ben Sorba; Moncef Mokni; Sadok Korbi
Journal:  Can Urol Assoc J       Date:  2011-02       Impact factor: 1.862

Review 3.  Gene translocations in musculoskeletal neoplasms.

Authors:  Balaji Krishnan; Gaurav Khanna; Denis Clohisy
Journal:  Clin Orthop Relat Res       Date:  2008-06-20       Impact factor: 4.176

Review 4.  Soft tissue sarcomas with non-EWS translocations: molecular genetic features and pathologic and clinical correlations.

Authors:  Cyril Fisher
Journal:  Virchows Arch       Date:  2009-04-28       Impact factor: 4.064

Review 5.  Inflammatory myofibroblastic tumors of the head and neck: evaluation of clinicopathologic and prognostic features.

Authors:  Kenneth O Devaney; Daniel J Lafeir; Asterios Triantafyllou; William M Mendenhall; Julia A Woolgar; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-05-16       Impact factor: 2.503

6.  ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition.

Authors:  Paul G Kemps; Jennifer Picarsic; Benjamin H Durham; Zofia Hélias-Rodzewicz; Laura Hiemcke-Jiwa; Cor van den Bos; Marianne D van de Wetering; Carel J M van Noesel; Jan A M van Laar; Robert M Verdijk; Uta E Flucke; Pancras C W Hogendoorn; F J Sherida H Woei-A-Jin; Raf Sciot; Andreas Beilken; Friedrich Feuerhake; Martin Ebinger; Robert Möhle; Falko Fend; Antje Bornemann; Verena Wiegering; Karen Ernestus; Tina Méry; Olga Gryniewicz-Kwiatkowska; Bozenna Dembowska-Baginska; Dmitry A Evseev; Vsevolod Potapenko; Vadim V Baykov; Stefania Gaspari; Sabrina Rossi; Marco Gessi; Gianpiero Tamburrini; Sébastien Héritier; Jean Donadieu; Jacinthe Bonneau-Lagacherie; Claire Lamaison; Laure Farnault; Sylvie Fraitag; Marie-Laure Jullié; Julien Haroche; Matthew Collin; Jackie Allotey; Majid Madni; Kerry Turner; Susan Picton; Pasquale M Barbaro; Alysa Poulin; Ingrid S Tam; Dina El Demellawy; Brianna Empringham; James A Whitlock; Aditya Raghunathan; Amy A Swanson; Mariko Suchi; Jon M Brandt; Nabeel R Yaseen; Joanna L Weinstein; Irem Eldem; Bryan A Sisk; Vaishnavi Sridhar; Mandy Atkinson; Lucas R Massoth; Jason L Hornick; Sanda Alexandrescu; Kee Kiat Yeo; Kseniya Petrova-Drus; Stephen Z Peeke; Laura S Muñoz-Arcos; Daniel G Leino; David D Grier; Robert Lorsbach; Somak Roy; Ashish R Kumar; Shipra Garg; Nishant Tiwari; Kristian T Schafernak; Michael M Henry; Astrid G S van Halteren; Oussama Abla; Eli L Diamond; Jean-François Emile
Journal:  Blood       Date:  2022-01-13       Impact factor: 22.113

7.  Inflammatory myofibroblastic tumor of the urinary bladder diagnosed by anaplastic lymphoma kinase immunostaining.

Authors:  Ram Nawal Rao; Priydarshi Ranjan; Nidhi Singla; Rakesh Pandey
Journal:  Urol Ann       Date:  2012-05

8.  Extensive rhabdomyosarcomatous differentiation in recurrent low-grade urothelial carcinoma of the bladder after transurethral resection: a case report.

Authors:  Maiko Kamei; Tsutomu Shinohara; Kotaro Kasahara; Takahira Kuno; Keishi Naruse; Hironobu Watanabe
Journal:  J Med Case Rep       Date:  2015-09-10

Review 9.  Inflammatory Myofibroblastic Tumor of the Liver: A Diagnostic Challenge.

Authors:  Gülsüm Özlem Elpek
Journal:  J Clin Transl Hepatol       Date:  2014-03-15

Review 10.  An Algorithmic Immunohistochemical Approach to Define Tumor Type and Assign Site of Origin.

Authors:  Andrew M Bellizzi
Journal:  Adv Anat Pathol       Date:  2020-05       Impact factor: 4.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.